Evidence map›Paper›PMID 28151998›Full record

ArticlePLoS computational biology2017

Effects of FGFR2 kinase activation loop dynamics on catalytic activity.

Jerome M Karp, Samuel Sparks, David Cowburn

Abstract read
In one paragraph

Article in PLoS computational biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jerome M KarpDepartment of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, United States of America.ORCID 0000-0001-7266-0946
Samuel SparksDepartment of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, United States of America.ORCID 0000-0002-7528-113X
David CowburnDepartment of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, United States of America.ORCID 0000-0001-6770-7172

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007288 · NIGMS · YESHIVA UNIVERSITY · PI AKABAS, MYLES H. · 1985 to 2022
$35.6M
Structural Biology of Protein KinasesR01GM047021 · NIGMS · ROCKEFELLER UNIVERSITY · PI COWBURN, DAVID · 1992 to 2008
$2.4M
Console and probe upgrade for 600 MHz NMRS10OD016305 · OD · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI COWBURN, DAVID · 2014 to 2014
$595k
NIGMS NIH HHS R01 GM047021NIGMS NIH HHS T32 GM007288NIH HHS S10 OD016305
6 · The paper itself

Abstract

The structural mechanisms by which receptor tyrosine kinases (RTKs) regulate catalytic activity are diverse and often based on subtle changes in conformational dynamics. The regulatory mechanism of one such RTK, fibroblast growth factor receptor 2 (FGFR2) kinase, is still unknown, as the numerous crystal structures of the unphosphorylated and phosphorylated forms of the kinase domains show no apparent structural change that could explain how phosphorylation could enable catalytic activity. In this study, we use several enhanced sampling molecular dynamics (MD) methods to elucidate the structural changes to the kinase's activation loop that occur upon phosphorylation. We show that phosphorylation favors inward motion of Arg664, while simultaneously favoring outward motion of Leu665 and Pro666. The latter structural change enables the substrate to bind leading to its resultant phosphorylation. Inward motion of Arg664 allows it to interact with the γ-phosphate of ATP as well as the substrate tyrosine. We show that this stabilizes the tyrosine and primes it for the catalytic phosphotransfer, and it may lower the activation barrier of the phosphotransfer reaction. Our work demonstrates the value of including dynamic information gleaned from computer simulation in deciphering RTK regulatory function.

Indexed as

Models, ChemicalMolecular Dynamics SimulationBinding SitesCatalysisEnzyme ActivationEnzyme StabilityProtein BindingProtein ConformationProtein DomainsReceptor, Fibroblast Growth Factor, Type 2Structure-Activity RelationshipTyrosineReceptor, Fibroblast Growth Factor, Type 2Tyrosine

Identifiers

PMID28151998
PMCPMC5313233

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.